A Phase 2a Trial Of Teplizumab And RN168 In Patients With New Onset Type 1 Diabetes Mellitus
Principal Investigator
Kevan Herold | Yale School of Medicine | New Haven, CT
Locations
Yale University | New Haven,CT
University of Florida | Gainesville,FL
Vanderbilt University | Nashville,TN
Barbara Davis Center | Aurora,CO
Benaroya Research Institute at Virginia Mason | Seattle,WA
Study Code
ITN831AI
Study Status
Terminated